These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 26771483)

  • 1. The Heroes of CRISPR.
    Lander ES
    Cell; 2016 Jan; 164(1-2):18-28. PubMed ID: 26771483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering.
    Liu Q; Zhang H; Huang X
    FEBS J; 2020 Feb; 287(4):626-644. PubMed ID: 31730297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering.
    Wright AV; Nuñez JK; Doudna JA
    Cell; 2016 Jan; 164(1-2):29-44. PubMed ID: 26771484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel CRISPR-Cas Systems: An Updated Review of the Current Achievements, Applications, and Future Research Perspectives.
    Nidhi S; Anand U; Oleksak P; Tripathi P; Lal JA; Thomas G; Kuca K; Tripathi V
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ecology and evolution of microbial CRISPR-Cas adaptive immune systems.
    Westra ER; van Houte S; Gandon S; Whitaker R
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20190101. PubMed ID: 30905294
    [No Abstract]   [Full Text] [Related]  

  • 6. Five big mysteries about CRISPR's origins.
    Ledford H
    Nature; 2017 Jan; 541(7637):280-282. PubMed ID: 28102279
    [No Abstract]   [Full Text] [Related]  

  • 7. CRISPR-Cas systems: beyond adaptive immunity.
    Westra ER; Buckling A; Fineran PC
    Nat Rev Microbiol; 2014 May; 12(5):317-26. PubMed ID: 24704746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panacea in progress: CRISPR and the future of its biological research introduction.
    Carroll M; Zhou X
    Microbiol Res; 2017 Aug; 201():63-74. PubMed ID: 28602403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas: evolution of an RNA-based adaptive immunity system in prokaryotes.
    Koonin EV; Makarova KS
    RNA Biol; 2013 May; 10(5):679-86. PubMed ID: 23439366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation in CRISPR-Cas Systems.
    Sternberg SH; Richter H; Charpentier E; Qimron U
    Mol Cell; 2016 Mar; 61(6):797-808. PubMed ID: 26949040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
    Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
    Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualization and prediction of CRISPR incidence in microbial trait-space to identify drivers of antiviral immune strategy.
    Weissman JL; Laljani RMR; Fagan WF; Johnson PLF
    ISME J; 2019 Oct; 13(10):2589-2602. PubMed ID: 31239539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of CRISPR/Cas9 system for targeted DNA modifications and recent improvements in modification efficiency and specificity.
    Shin J; Oh JW
    BMB Rep; 2020 Jul; 53(7):341-348. PubMed ID: 32580834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic and diagnostic relevance of Crispr technology.
    El Ouar I; Djekoun A
    Biomed Pharmacother; 2021 Jun; 138():111487. PubMed ID: 33774312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
    Hwang S; Maxwell KL
    CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SnapShot: CRISPR-RNA-guided adaptive immune systems.
    Carter J; Wiedenheft B
    Cell; 2015 Sep; 163(1):260-260.e1. PubMed ID: 26406380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An history of the CRISPR-Cas systems discovery].
    Pourcel C
    Biol Aujourdhui; 2017; 211(4):247-254. PubMed ID: 29956651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In defense of phage: viral suppressors of CRISPR-mediated adaptive immunity in bacteria.
    Wiedenheft B
    RNA Biol; 2013 May; 10(5):886-90. PubMed ID: 23392292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas: From the Bacterial Adaptive Immune System to a Versatile Tool for Genome Engineering.
    Kirchner M; Schneider S
    Angew Chem Int Ed Engl; 2015 Nov; 54(46):13508-14. PubMed ID: 26382836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral diversity threshold for adaptive immunity in prokaryotes.
    Weinberger AD; Wolf YI; Lobkovsky AE; Gilmore MS; Koonin EV
    mBio; 2012 Dec; 3(6):e00456-12. PubMed ID: 23221803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.